The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world treatment patterns and overall survival (OS) in patients (pts) with HER2-positive (HER2+) advanced or metastatic gastroesophageal adenocarcinomas (mGEA) in the US.
 
Farshid Dayyani
Consulting or Advisory Role - AstraZeneca; Eisai; Jazz Pharmaceuticals
Speakers' Bureau - Astellas Pharma; beone; ipsen; Sirtex Medical; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech (Inst); Ipsen (Inst); Merck (Inst); Taiho Pharmaceutical (Inst)
 
Xiaozhou Fan
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Joan Zape
Employment - Jazz Pharmaceuticals
 
Roderick Murphy
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Keith Betts
Consulting or Advisory Role - Analysis Group
 
Yan Wang
Employment - Analysis Group
 
Shuang Wang
Employment - Moderna Therapeutics (I)
Stock and Other Ownership Interests - Moderna Therapeutics (I)
Travel, Accommodations, Expenses - Moderna Therapeutics (I)
 
Ariel Chao
Consulting or Advisory Role - Analysis Group
 
Wenqing Su
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Jazz Pharmaceuticals
 
Douglas Fuller
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Javier Sabater
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Michael Gibson
Stock and Other Ownership Interests - PapiVax Biotech, Inc.; PharmaJet
Honoraria - Astellas Pharma; Coherus BioSciences; Daiichi Sankyo/Lilly; Regeneron
Consulting or Advisory Role - Abbvie; Regeneron; UpToDate
Research Funding - Daiichi Sankyo/Lilly (Inst); Juntendo University Medical Center (Inst); PapiVax Biotech, Inc. (Inst)
 
Peter Enzinger
Consulting or Advisory Role - ALX Oncology; Amgen; Amgen; Arcus Biosciences; Arcus Biosciences; Arcus Biosciences; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Bayer; BeiGene; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene; Celgene; Chimeric Therapeutics; Chimeric Therapeutics; Coherus Biosciences; Daiichi Sankyo; Daiichi Sankyo/Astra Zeneca; Eisai; Eisai; Fosun Pharma; Gilead Sciences; Henlius; IDEAYA Biosciences; ImmPACT Bio; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Legend Biotech ; Legend Biotech; Legend Biotech; Lilly; loxo; Loxo; Merck; Novartis; Novartis; Oncolys BioPharma; Oncolys BioPharma; Ono Pharmaceutical; Oxford BioTherapeutics; Regeneron; Regeneron; Sanofi; Sanofi/Aventis; SERVIER; SERVIER; Taiho Oncology; Taiho Pharmaceutical; Takeda; Takeda; Turning Point Therapeutics; Turning Point Therapeutics; Xencor; Xencor; Zymeworks